Zhang Xiao, Zhang Rui, Yu Jinpu
Cancer Molecular Diagnostics Core, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center of Caner, Key Laboratory of Cancer Prevention and Therapy, Key Laboratory of Cancer Immunology and Biotherapy, Tianjin, China.
Tianjin's Clinical Research Center for Cancer, Tianjin, China.
Front Cell Dev Biol. 2020 Aug 7;8:657. doi: 10.3389/fcell.2020.00657. eCollection 2020.
Long interspersed nuclear element-1 (LINE-1) retrotransposition is a major hallmark of cancer accompanied by global chromosomal instability, genomic instability, and genetic heterogeneity and has become one indicator for the occurrence, development, and poor prognosis of many diseases. LINE-1 also modulates the immune system and affects the immune microenvironment in a variety of ways. Aberrant expression of LINE-1 retrotransposon can provide strong stimuli for an innate immune response, activate the immune system, and induce autoimmunity and inflammation. Therefore, inhibition the activity of LINE-1 has become a potential treatment strategy for various diseases. In this review, we discussed the components and regulatory mechanisms involved with LINE-1, its correlations with disease and immunity, and multiple inhibitors of LINE-1, providing a new understanding of LINE-1.
长散在核元件1(LINE-1)逆转录转座是癌症的一个主要标志,伴随着全球染色体不稳定、基因组不稳定和遗传异质性,已成为许多疾病发生、发展和预后不良的一个指标。LINE-1还调节免疫系统,并以多种方式影响免疫微环境。LINE-1逆转座子的异常表达可对先天性免疫反应提供强烈刺激,激活免疫系统,并诱导自身免疫和炎症。因此,抑制LINE-1的活性已成为各种疾病的一种潜在治疗策略。在本综述中,我们讨论了与LINE-1相关的组成部分和调控机制、其与疾病和免疫的相关性以及LINE-1的多种抑制剂,从而对LINE-1有了新的认识。